Piroxicam in osteoarthritis: a controlled long-term study.

T. M. Zizic, M. B. Stevens, J. D. Sutton

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


This six-month double-blind, parallel-design study compared the efficacy and safety of piroxicam 20 mg and 40 mg with that of 12 tablets of aspirin in 29 patients with osteoarthritis and demonstrated that both piroxicam doses were superior to aspirin in the treatment of osteoarthritis with respect to physicians' opinion of improvement and ease of movement. The safety of piroxicam 20 mg and aspirin were comparable, with gastrointestinal side effects being the most prevalent adverse effect. Patients receiving piroxicam are continuing in a five-year efficacy and safety study.

Original languageEnglish (US)
Pages (from-to)32-40
Number of pages9
JournalPostgraduate medicine
VolumeSpec No
StatePublished - May 1 1983
Externally publishedYes

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Piroxicam in osteoarthritis: a controlled long-term study.'. Together they form a unique fingerprint.

Cite this